Our Pricing

Who Can Safely Take Promethazine (Phenergan)?

Understanding who can take promethazine UK safely is essential before starting treatment with this antihistamine medication. Promethazine, commonly known as Phenergan, is a versatile medication used for allergies, motion sickness, nausea, and short-term sleep disturbances, but it's not suitable for everyone. At Cured Pharmacy, our UK-registered clinical team assesses each patient's suitability through a free online consultation to ensure safe, appropriate prescribing.

Who Can Take Promethazine Safely?

Promethazine is licensed in the UK for adults and children over 2 years of age, though specific age restrictions apply depending on the indication [1]. For allergic conditions and nausea, children aged 2 years and older may be prescribed promethazine elixir at appropriate doses. However, for sleep disturbances, the MHRA restricts use to adults and children aged 16 years and over due to potential respiratory depression risks in younger children [2].

Adults without contraindications can safely use promethazine 25mg tablets for hay fever, allergic skin reactions, motion sickness, and short-term insomnia. The medication works by blocking histamine H1 receptors, reducing allergic symptoms, and producing sedative effects that can aid sleep [1]. At Cured Pharmacy, we offer Phenergan 25mg Tablets x56 from £17.54, Phenergan Elixir from £17.54 for paediatric dosing, and Phenergan Night Tablets 25mg from £17.54 for short-term sleep support.

Pregnant women should only use promethazine when the potential benefits outweigh the risks, and always under medical supervision. While not contraindicated in pregnancy, promethazine crosses the placental barrier and should be avoided in the two weeks before delivery due to potential effects on the newborn [3]. Breastfeeding mothers should consult their GP or pharmacist, as small amounts of promethazine pass into breast milk and may cause drowsiness in nursing infants.

Absolute Contraindications: Who Should Not Take Promethazine

Certain groups must avoid promethazine entirely due to serious safety concerns. Children under 2 years of age should never receive promethazine, as respiratory depression risk is significantly elevated in this age group [2]. The MHRA issued specific warnings following reports of fatal respiratory events in young children, making this an absolute contraindication.

Patients with known hypersensitivity to promethazine, other phenothiazines, or any excipients in the formulation must not use this medication. Severe allergic reactions, including anaphylaxis, have been documented in sensitised individuals [1]. Additionally, promethazine is contraindicated in patients who have taken monoamine oxidase inhibitors (MAOIs) within the previous 14 days, as this combination can cause dangerous interactions affecting blood pressure and central nervous system function.

Respiratory and Neurological Contraindications

Patients with severe respiratory depression, acute asthma attacks, or chronic obstructive pulmonary disease (COPD) requiring careful respiratory monitoring should avoid promethazine due to its sedative properties that may further suppress breathing [2]. Those with epilepsy or seizure disorders require careful assessment, as phenothiazines can lower the seizure threshold and potentially trigger convulsions. Comatose patients or those with severe central nervous system depression from alcohol, barbiturates, or opioids must not receive promethazine, as additive sedation poses life-threatening risks.

Medical Conditions Requiring Caution with Promethazine

Several medical conditions don't absolutely prohibit promethazine use but require careful prescriber assessment and monitoring. Patients with cardiovascular disease, particularly those with heart rhythm abnormalities, need evaluation before starting treatment, as phenothiazines can prolong the QT interval on electrocardiograms [3]. This effect increases the risk of serious arrhythmias, especially when combined with other QT-prolonging medications.

Liver disease affects promethazine metabolism, potentially leading to drug accumulation and enhanced sedative effects. Patients with hepatic impairment may require dose adjustments or alternative treatments. Similarly, those with severe kidney disease should be monitored closely, as reduced renal function can affect drug clearance. Elderly patients often have age-related decline in both liver and kidney function, making them particularly susceptible to promethazine's sedative and anticholinergic effects [1].

Patients with glaucoma, particularly angle-closure glaucoma, should use promethazine with extreme caution or avoid it entirely. The medication's anticholinergic properties can increase intraocular pressure, potentially precipitating an acute glaucoma attack [2]. Prostatic hypertrophy and urinary retention are also relative contraindications, as promethazine can worsen urinary obstruction through its anticholinergic effects.

Metabolic and Blood Disorders

Patients with bone marrow depression or blood dyscrasias require careful monitoring, as phenothiazines have been associated with agranulocytosis and other haematological effects in rare cases [3]. Those with phaeochromocytoma should avoid promethazine due to potential hypertensive crisis. Patients with Reye's syndrome or suspected Reye's syndrome must not receive promethazine, as the medication's antiemetic properties may mask early symptoms and delay diagnosis of this serious condition.

Age-Specific Eligibility for Promethazine in the UK

Age plays a crucial role in determining promethazine eligibility and appropriate formulations. For children aged 2-5 years, promethazine elixir is the preferred formulation for allergic conditions and nausea, with dosing carefully calculated based on body weight. The typical dose is 0.5mg per kilogram of body weight, given as a single evening dose or in divided doses throughout the day [1]. Our Phenergan Elixir from £17.54 provides accurate dosing for paediatric patients when prescribed by a UK clinician.

Children aged 5-16 years may receive higher doses for allergic conditions and motion sickness, but promethazine should not be used for sleep disturbances in this age group due to MHRA restrictions [2]. Adolescents aged 16 years and over can use adult dosing regimens, including Phenergan Night Tablets 25mg from £17.54 for short-term insomnia lasting no more than 7 consecutive nights.

Elderly patients require special consideration due to increased sensitivity to anticholinergic and sedative effects. Falls risk is significantly elevated in older adults taking promethazine, particularly when used as a sleep aid [3]. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures that prescribing for elderly patients includes thorough assessment of fall risk, cognitive function, and concurrent medications that may interact with promethazine.

Drug Interactions Affecting Promethazine Eligibility

Concurrent medications significantly influence whether promethazine is appropriate for individual patients. Central nervous system depressants, including benzodiazepines, opioid analgesics, barbiturates, and alcohol, interact additively with promethazine, producing profound sedation and respiratory depression [1]. Patients taking these medications regularly may not be suitable candidates for promethazine, or may require substantially reduced doses under close medical supervision.

Anticholinergic medications such as tricyclic antidepressants, antihistamines, antispasmodics, and certain bladder control medications produce additive anticholinergic effects when combined with promethazine. This combination increases risks of dry mouth, constipation, urinary retention, confusion, and heat stroke, particularly in elderly patients [2]. Our online consultation process specifically screens for these interactions to ensure safe prescribing.

Medications that prolong the QT interval, including certain antibiotics (erythromycin, clarithromycin), antipsychotics, and antiarrhythmics, should be used cautiously with promethazine due to cumulative cardiac effects [3]. Patients taking MAOIs must wait 14 days after discontinuing these medications before starting promethazine. Additionally, promethazine may interfere with allergy skin testing, producing false-negative results, so it should be discontinued at least 72 hours before scheduled allergy testing.

Enzyme Inhibitors and Inducers

Medications that inhibit cytochrome P450 enzymes, particularly CYP2D6, can increase promethazine plasma concentrations and enhance sedative effects. Conversely, enzyme inducers like rifampicin, carbamazepine, and phenytoin may reduce promethazine effectiveness by accelerating its metabolism [1]. Your UK prescriber will review your complete medication list during the online consultation to identify potential interactions before prescribing promethazine.

How Cured Pharmacy Assesses Promethazine Suitability

At Cured Pharmacy, every promethazine request undergoes clinical assessment by a UK-registered prescriber before dispensing. Our free online consultation, completed in under 3 minutes, collects essential medical history including current medications, allergies, existing medical conditions, and previous reactions to antihistamines. This thorough screening ensures that promethazine is clinically appropriate and safe for your individual circumstances.

Our clinical team specifically evaluates contraindications outlined by the MHRA and assesses whether promethazine is the most suitable treatment for your presenting symptoms. For patients with relative contraindications, alternative antihistamines with different safety profiles may be recommended. We maintain transparent upfront pricing, with costs displayed before you complete the consultation, ensuring no unexpected charges.

All medicines dispensed by Cured Pharmacy are genuine UK-licensed products sourced from MHRA-approved wholesalers. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees clinical governance and ensures compliance with General Pharmaceutical Council standards. We provide discreet packaging and offer guidance on safe use, potential side effects, and when to seek medical attention. If promethazine is deemed unsuitable during your assessment, our prescribers will explain why and suggest appropriate alternatives where available.

Ongoing Monitoring and Support

Short-term use of promethazine for allergies, motion sickness, or sleep disturbances typically doesn't require ongoing monitoring. However, patients experiencing unusual side effects, inadequate symptom relief, or those requiring treatment beyond recommended durations should contact our pharmacy team on (+44) 116 4646009 or consult their GP. Promethazine for sleep should not be used for more than 7 consecutive nights without medical review, as tolerance and dependence can develop with prolonged use [2].

Scientific References

1. Electronic Medicines Compendium. (2023). Phenergan 25mg Tablets - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/5398/smpc
2. Medicines and Healthcare products Regulatory Agency. (2019). Promethazine for sleep: new age limit and pack size restrictions. Drug Safety Update, 12(10), 1-2. https://www.gov.uk/drug-safety-update/promethazine-for-sleep-new-age-limit-and-pack-size-restrictions
3. British National Formulary. (2024). Promethazine hydrochloride. National Institute for Health and Care Excellence. https://bnf.nice.org.uk/drugs/promethazine-hydrochloride/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.